title: Drug Access Is Improved By The Essential Drug System And "Low-Priced Drug" Policy In China.
authors.affiliation: AstraZeneca, Beijing, China.
authors.forename: M
authors.initials: M
authors.lastname: Liu
authors.affiliation: AstraZeneca, Beijing, China.
authors.forename: L
authors.initials: L
authors.lastname: Huang
authors.affiliation: AstraZeneca, Beijing, China.
authors.forename: D
authors.initials: D
authors.lastname: Zhao
authors.affiliation: AstraZeneca, Beijing, China.
authors.forename: L
authors.initials: L
authors.lastname: Xu